JVM Co

JVM Co Long-term Debt

The Long-Term Debt of JVM Co (054950.KQ) as of Nov 3, 2026 is 639.17 M KRW. In the previous year, Long-Term Debt was 659.63 M KRW — a change of -3.10% (lower).

Long-term Debt

639.17 MKRW

YoY

-3.10%

Last updated:

Long-Term Debt of JVM Co is 2024 639.17 M KRW. Long-Term Debt of JVM Co was 2023 659.63 M KRW. It decreases by -3.10% lower compared to the previous year.

The JVM Co Long-term Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Long-term Debt
Date
Long-term Debt
Jan 1, 2017
0.00 KRW
Jan 1, 2018
0.00 KRW
Jan 1, 2019
345.37 M KRW
Jan 1, 2020
415.18 M KRW
Jan 1, 2021
543.26 M KRW
Jan 1, 2022
813.55 M KRW
Jan 1, 2023
659.63 M KRW
Jan 1, 2024
639.17 M KRW
The JVM Co Long-term Debt history
YEARLong-term DebtYoY
639.17 MKRW-3.10%
659.63 MKRW-18.92%
813.55 MKRW+49.75%
543.26 MKRW+30.85%
415.18 MKRW+20.21%
345.37 MKRW—
0.00KRW—
0.00KRW-100.00%
1.96 BKRW-6.96%
2.11 BKRW-23.68%
2.77 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JVM Co Stock analysis

What does JVM Co do? JVM Co., Ltd. manufactures pharmacy automation systems under the brand JVM, targeting domestic and overseas markets. The company's primary products include automatic tablet dispensing and packaging systems (ATDPSs), automatic tablet classification and packing machines available in slide, box, and drum types, total safety solutions, automatic medication vision inspection systems (VIZENs), automatic package cutting and winding systems (WIZERs), and automatic medication sorting and control systems (AccuPharm). These products are sold to customers in the pharmaceutical and healthcare sectors seeking efficient automation solutions for medication handling and safety. The firm generates revenue through the sale of its branded automation systems, with a focus on domestic distribution and international markets. JVM's product portfolio addresses key operational needs in pharmacy settings, including dispensing, classification, inspection, and sorting of medications, ensuring compliance with safety standards while improving workflow efficiency. The company's offerings are designed to meet the demands of healthcare providers and pharmaceutical manufacturers requiring advanced automation technologies. JVM's business model centers on providing comprehensive automation solutions for pharmacy operations, leveraging its established brand JVM to differentiate its products in the market. By offering a wide range of specialized systems, the company caters to both domestic and international clients seeking reliable, high-quality automation equipment for medication management and safety protocols. JVM Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JVM Co stock

Long-Term Debt of JVM Co is 639.17 M KRW in 2024.

Long-Term Debt of JVM Co changed from 659.63 M KRW to 639.17 M KRW, representing a -3.10% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Long-Term Debt JVM Co since 2006 – with annual values, charts, and detailed analysis.

Long-term debt represents obligations due after one year. It is a key component of a company's capital structure and leverage.

Long-Term Debt's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Long-Term Debt's JVM Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — JVM Co

All Key Metrics — JVM Co